• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半胱天冬酶非依赖性调控坏死途径作为癌症治疗的潜在靶点

Caspase-Independent Regulated Necrosis Pathways as Potential Targets in Cancer Management.

作者信息

Lou Jianyao, Zhou Yunxiang, Feng Zengyu, Ma Mindi, Yao Yihan, Wang Yali, Deng Yongchuan, Wu Yulian

机构信息

Department of General Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Department of Surgical Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

出版信息

Front Oncol. 2021 Feb 16;10:616952. doi: 10.3389/fonc.2020.616952. eCollection 2020.

DOI:10.3389/fonc.2020.616952
PMID:33665167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7921719/
Abstract

Regulated necrosis is an emerging type of cell death independent of caspase. Recently, with increasing findings of regulated necrosis in the field of biochemistry and genetics, the underlying molecular mechanisms and signaling pathways of regulated necrosis are gradually understood. Nowadays, there are several modes of regulated necrosis that are tightly related to cancer initiation and development, including necroptosis, ferroptosis, parthanatos, pyroptosis, and so on. What's more, accumulating evidence shows that various compounds can exhibit the anti-cancer effect inducing regulated necrosis in cancer cells, which indicates that caspase-independent regulated necrosis pathways are potential targets in cancer management. In this review, we expand the molecular mechanisms as well as signaling pathways of multiple modes of regulated necrosis. We also elaborate on the roles they play in tumorigenesis and discuss how each of the regulated necrosis pathways could be therapeutically targeted.

摘要

程序性坏死是一种独立于半胱天冬酶的新型细胞死亡方式。近年来,随着生物化学和遗传学领域对程序性坏死的研究发现不断增加,程序性坏死的潜在分子机制和信号通路逐渐被人们所了解。目前,有几种程序性坏死模式与癌症的发生和发展密切相关,包括坏死性凋亡、铁死亡、PARP 依赖性细胞坏死、焦亡等。此外,越来越多的证据表明,各种化合物可以通过诱导癌细胞发生程序性坏死来发挥抗癌作用,这表明不依赖半胱天冬酶的程序性坏死途径是癌症治疗的潜在靶点。在这篇综述中,我们阐述了多种程序性坏死模式的分子机制和信号通路。我们还详细讨论了它们在肿瘤发生中的作用,并探讨了如何将每种程序性坏死途径作为治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf6/7921719/07b01446d31c/fonc-10-616952-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf6/7921719/2a6848ff2170/fonc-10-616952-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf6/7921719/07b01446d31c/fonc-10-616952-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf6/7921719/2a6848ff2170/fonc-10-616952-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf6/7921719/07b01446d31c/fonc-10-616952-g002.jpg

相似文献

1
Caspase-Independent Regulated Necrosis Pathways as Potential Targets in Cancer Management.半胱天冬酶非依赖性调控坏死途径作为癌症治疗的潜在靶点
Front Oncol. 2021 Feb 16;10:616952. doi: 10.3389/fonc.2020.616952. eCollection 2020.
2
Multiple types of programmed necrosis such as necroptosis, pyroptosis, oxytosis/ferroptosis, and parthanatos contribute simultaneously to retinal damage after ischemia-reperfusion.多种类型的程序性细胞坏死,如坏死性凋亡、细胞焦亡、氧化应激/铁死亡和 PARthanatos,在缺血再灌注后同时导致视网膜损伤。
Sci Rep. 2022 Oct 13;12(1):17152. doi: 10.1038/s41598-022-22140-0.
3
Programmed necrotic cell death of macrophages: Focus on pyroptosis, necroptosis, and parthanatos.程序性巨噬细胞坏死:聚焦细胞焦亡、坏死性凋亡和PARP 过度激活诱导的细胞坏死。
Redox Biol. 2019 Sep;26:101239. doi: 10.1016/j.redox.2019.101239. Epub 2019 Jun 9.
4
Regulated Necrosis in Pulmonary Disease. A Focus on Necroptosis and Ferroptosis.调控性细胞坏死在肺部疾病中的作用:聚焦坏死性凋亡和铁死亡。
Am J Respir Cell Mol Biol. 2020 May;62(5):554-562. doi: 10.1165/rcmb.2019-0337TR.
5
Regulated necrosis and its implications in toxicology.程序性坏死及其在毒理学中的意义。
Toxicology. 2015 Jul 3;333:118-126. doi: 10.1016/j.tox.2015.04.003. Epub 2015 Apr 9.
6
Involvement of regulated necrosis in blinding diseases: Focus on necroptosis and ferroptosis.调控性细胞坏死在致盲性疾病中的作用:聚焦于坏死性凋亡和铁死亡。
Exp Eye Res. 2020 Feb;191:107922. doi: 10.1016/j.exer.2020.107922. Epub 2020 Jan 7.
7
Parthanatos and its associated components: Promising therapeutic targets for cancer.细胞坏死性凋亡及其相关成分:癌症治疗的有前景靶点。
Pharmacol Res. 2021 Jan;163:105299. doi: 10.1016/j.phrs.2020.105299. Epub 2020 Nov 7.
8
An Overview of Pathways of Regulated Necrosis in Acute Kidney Injury.急性肾损伤中程序性坏死途径概述
Semin Nephrol. 2016 May;36(3):139-52. doi: 10.1016/j.semnephrol.2016.03.002.
9
Necroptosis: A new way of dying?坏死性凋亡:一种新的死亡方式?
Cancer Biol Ther. 2016 Sep;17(9):899-910. doi: 10.1080/15384047.2016.1210732. Epub 2016 Jul 19.
10
The Role of Programmed Necrosis in Colorectal Cancer.程序性坏死在结直肠癌中的作用
Cancers (Basel). 2022 Sep 1;14(17):4295. doi: 10.3390/cancers14174295.

引用本文的文献

1
Natural Nrf2 activators modulate antioxidant gene expression and apoptosis in leukemic K-562 cells.天然Nrf2激活剂调节白血病K-562细胞中的抗氧化基因表达和细胞凋亡。
Med Oncol. 2025 Jul 31;42(9):396. doi: 10.1007/s12032-025-02946-4.
2
Parthanatos and apoptosis: unraveling their roles in cancer cell death and therapy resistance.PARP-1依赖性细胞坏死与细胞凋亡:揭示它们在癌细胞死亡和治疗抗性中的作用
EXCLI J. 2025 Mar 4;24:351-380. doi: 10.17179/excli2025-8251. eCollection 2025.
3
Advancements in programmed cell death research in antitumor therapy: a comprehensive overview.

本文引用的文献

1
Parthanatos and its associated components: Promising therapeutic targets for cancer.细胞坏死性凋亡及其相关成分:癌症治疗的有前景靶点。
Pharmacol Res. 2021 Jan;163:105299. doi: 10.1016/j.phrs.2020.105299. Epub 2020 Nov 7.
2
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance.基于纳米颗粒的药物递送在癌症治疗中的应用及其在克服耐药性方面的作用。
Front Mol Biosci. 2020 Aug 20;7:193. doi: 10.3389/fmolb.2020.00193. eCollection 2020.
3
Dissecting Programmed Cell Death with Small Molecules.小分子解析细胞程序性死亡。
肿瘤治疗中程序性细胞死亡研究的进展:全面综述
Apoptosis. 2025 Feb;30(1-2):401-421. doi: 10.1007/s10495-024-02038-0. Epub 2024 Nov 2.
4
Pyroptosis and chemical classification of pyroptotic agents.细胞焦亡及细胞焦亡诱导剂的化学分类
Mol Divers. 2025 Jun;29(3):2765-2782. doi: 10.1007/s11030-024-10987-6. Epub 2024 Sep 24.
5
A pyroptosis-related lncRNA-based prognostic index for hepatocellular carcinoma by relative expression orderings.一种基于细胞焦亡相关长链非编码RNA的肝细胞癌预后指数,通过相对表达排序得出。
Transl Cancer Res. 2024 Mar 31;13(3):1406-1424. doi: 10.21037/tcr-23-1804. Epub 2024 Mar 25.
6
D-Amino acids differentially trigger an inflammatory environment in vitro.D-氨基酸在体外差异地引发炎症环境。
Amino Acids. 2024 Feb 3;56(1):6. doi: 10.1007/s00726-023-03360-8.
7
Genome, Metabolism, or Immunity: Which Is the Primary Decider of Pancreatic Cancer Fate through Non-Apoptotic Cell Death?基因组、代谢还是免疫:通过非凋亡性细胞死亡决定胰腺癌命运的首要因素是什么?
Biomedicines. 2023 Oct 14;11(10):2792. doi: 10.3390/biomedicines11102792.
8
Amplifying cancer treatment: advances in tumor immunotherapy and nanoparticle-based hyperthermia.放大癌症治疗:肿瘤免疫治疗和基于纳米粒子的热疗的进展。
Front Immunol. 2023 Oct 6;14:1258786. doi: 10.3389/fimmu.2023.1258786. eCollection 2023.
9
Pyroptosis-related gene signatures are associated with prognosis and tumor microenvironment infiltration in head and neck cancer.焦亡相关基因特征与头颈癌的预后及肿瘤微环境浸润相关。
Health Sci Rep. 2023 Oct 12;6(10):e1622. doi: 10.1002/hsr2.1622. eCollection 2023 Oct.
10
Primary cilia suppress Ripk3-mediated necroptosis.原发性纤毛抑制Ripk3介导的坏死性凋亡。
Cell Death Discov. 2022 Dec 2;8(1):477. doi: 10.1038/s41420-022-01272-2.
Acc Chem Res. 2020 May 19;53(5):1034-1045. doi: 10.1021/acs.accounts.9b00600. Epub 2020 Apr 16.
4
Targeting apoptosis in cancer therapy.靶向细胞凋亡治疗癌症。
Nat Rev Clin Oncol. 2020 Jul;17(7):395-417. doi: 10.1038/s41571-020-0341-y. Epub 2020 Mar 23.
5
Necroptosis-Inducible Polymeric Nanobubbles for Enhanced Cancer Sonoimmunotherapy.诱导细胞坏死的聚合物纳米气泡用于增强癌症声免疫治疗
Adv Mater. 2020 Apr;32(16):e1907953. doi: 10.1002/adma.201907953. Epub 2020 Mar 3.
6
Autophagy: A Potential Therapeutic Target of Polyphenols in Hepatocellular Carcinoma.自噬:多酚在肝细胞癌中的潜在治疗靶点
Cancers (Basel). 2020 Feb 29;12(3):562. doi: 10.3390/cancers12030562.
7
A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3).经阴道青蒿琥酯治疗宫颈上皮内瘤变 2/3(CIN2/3)的首例人体概念验证试验。
Gynecol Oncol. 2020 Apr;157(1):188-194. doi: 10.1016/j.ygyno.2019.12.035. Epub 2020 Jan 28.
8
Ferroptosis-driven nanotherapeutics for cancer treatment.铁死亡驱动的癌症治疗纳米疗法。
J Control Release. 2020 Mar 10;319:322-332. doi: 10.1016/j.jconrel.2020.01.008. Epub 2020 Jan 7.
9
Cell death mechanisms in eukaryotes.真核生物细胞死亡机制。
Cell Biol Toxicol. 2020 Apr;36(2):145-164. doi: 10.1007/s10565-019-09496-2. Epub 2019 Dec 9.
10
Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis.突变 BRAF 和 MEK 抑制剂通过细胞焦亡调节肿瘤免疫微环境。
Cancer Discov. 2020 Feb;10(2):254-269. doi: 10.1158/2159-8290.CD-19-0672. Epub 2019 Dec 3.